Cytokinetics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 762M 80.42M 2025-06
Amgen USD 8.03B 782M 2025-06
Bayer EUR 4.56B 542M 2025-06
Biogen USD 2.76B 160.5M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Cytokinetics USD 74.94M 863.28M 2025-06
Eisai JPY 285.38B 19.82B 2025-06
Eli Lilly USD 3.38B 282.6M 2025-06
Exelixis USD 164.43M 19.32M 2025-06
Geron USD 79.6M 6.01M 2025-06
Halozyme Therapeutics USD 61.86M 114.47M 2025-06
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
Ligand Pharmaceuticals USD 67.67M 189.22M 2025-06
Merck USD 8.01B 622M 2025-06
Novartis USD 6.66B 410M 2025-06
Pfizer USD 1.64B 208M 2025-06
Regeneron Pharmaceuticals USD 2B 1.09B 2025-06
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 15.36B 7.37B 2025-06


Cytokinetics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.